In 2004, the FDA warned the public that antidepressant use could increase the risk of suicidal thoughts or actions in adolescents–and it required all makers of antidepressant drugs to add to the drugs a dreaded "black box" warning. Now a group of researchers from Harvard is presenting rather compelling evidence that the FDA's action might have been a mistake.
written on 19.06.2014